Paper9844827
The optimization of helper T lymphocyte (HTL) function in vaccine development.
Alexander J and 10 others. Immunol Res, 1998. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. The optimization of helper T lymphocyte (HTL) function in vaccine development. Papers, record 9844827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9844827
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epitopes | Major topic |
| HLA-DR Antigens | Major topic |
| T-Lymphocytes, Helper-Inducer | Major topic |
| Vaccines, Synthetic | Major topic |
| Animals | |
| Antigens, Protozoan | |
| B-Lymphocytes | |
| Hepatitis B Vaccines | |
| Humans | |
| Immunity, Cellular | |
| Malaria | |
| Mice | |
| Plasmodium | |
| Protozoan Proteins | |
| T-Lymphocytes, Cytotoxic |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| N01-AI-45241 | NIAID NIH HHS | United States | N01AI045241 | PubMed and NIH | NIH RePORTER |
| R01 AI 2001 | NIAID NIH HHS | United States | PubMed | PubMed | |
| R37 CA 40489 | NCI NIH HHS | United States | R37CA040489 | PubMed and NIH | NIH RePORTER |
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8093457 | The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. | J Immunol | 1993 | https://conductscience.org/library/papers/8093457 | PubMed |
| 2 | 2230128 | Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. | J Immunol | 1990 | https://conductscience.org/library/papers/2230128 | PubMed |
| 3 | 9252123 | Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. | Immunity | 1997 | https://conductscience.org/library/papers/9252123 | PubMed |
| 4 | 10072562 | Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. | J Immunol | 1999 | https://conductscience.org/library/papers/10072562 | PubMed |
| 5 | 9029118 | Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. | J Immunol | 1997 | https://conductscience.org/library/papers/9029118 | PubMed |
| 6 | 7836921 | Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. | J Exp Med | 1995 | https://conductscience.org/library/papers/7836921 | PubMed |
| 7 | 1401902 | DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. | J Immunol | 1992 | https://conductscience.org/library/papers/1401902 | PubMed |
| 8 | 2463305 | Delineation of several DR-restricted tetanus toxin T cell epitopes. | J Immunol | 1989 | https://conductscience.org/library/papers/2463305 | PubMed |
| 9 | 7814635 | Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7814635 | PubMed |
| 10 | 1717570 | On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. | J Immunol | 1991 | https://conductscience.org/library/papers/1717570 | PubMed |
| 11 | 2717617 | Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2717617 | PubMed |
| 12 | 1684784 | Selective activation of Th1- and Th2-like cells in vivo--response to human collagen IV. | Immunol Rev | 1991 | https://conductscience.org/library/papers/1684784 | PubMed |
| 13 | 1711074 | Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells. | J Immunol | 1991 | https://conductscience.org/library/papers/1711074 | PubMed |
| 14 | 2094592 | Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. | Bull World Health Organ | 1990 | https://conductscience.org/library/papers/2094592 | PubMed |
| 15 | 8476576 | T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. | Annu Rev Immunol | 1993 | https://conductscience.org/library/papers/8476576 | PubMed |
| 16 | 8316295 | Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. | Nature | 1993 | https://conductscience.org/library/papers/8316295 | PubMed |
| 17 | 8145819 | Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. | Nature | 1994 | https://conductscience.org/library/papers/8145819 | PubMed |
| 18 | 2963699 | Structural model of HLA-DR1 restricted T cell antigen recognition. | Cell | 1988 | https://conductscience.org/library/papers/2963699 | PubMed |
| 19 | 1967273 | CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells. | J Immunol | 1990 | https://conductscience.org/library/papers/1967273 | PubMed |
| 20 | 2481588 | Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. | Eur J Immunol | 1989 | https://conductscience.org/library/papers/2481588 | PubMed |
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984541 | Rational design of a multi-epitope vaccine targeting the stress-associated proteins for Mycoplasma fermentans via immunoinformatics. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42984541 | PubMed |
| 42797492 | Pangenome-Guided In Silico Design and Structural Evaluation of a Multi-Epitope Vaccine Candidate Against Streptococcus suis. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797492 | PubMed |
| 42045246 | Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/42045246 | PubMed |
| 41901794 | Multi-Epitope DNA-Based Feline Immunodeficiency Virus Vaccine Construct Designed by Immunoinformatic and Machine Learning Tools as a Surrogate Model for HIV Vaccine Development. | Pathogens | 2026 | https://conductscience.org/library/papers/41901794 | PubMed |
| 41752180 | A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752180 | PubMed |
| 41654930 | Computational design of a novel multi-epitope vaccine candidate against group A rotavirus. | Virol J | 2026 | https://conductscience.org/library/papers/41654930 | PubMed |
| 41459947 | Analysis of MHC class II-bound CyHV-2 peptides in Carassius gibelio using mass spectrometry. | J Virol | 2026 | https://conductscience.org/library/papers/41459947 | PubMed |
| 41304878 | Computational Development of Multi-Epitope Reovirus Vaccine with Potent Predicted Binding to TLR2 and TLR4. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304878 | PubMed |
| 41154730 | Consensus-Guided Construction of H5N1-Specific and Universal Influenza a Multiepitope Vaccines. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41154730 | PubMed |
| 41011130 | In Silico Development of a Chimeric Multi-Epitope Vaccine Targeting Helcococcus kunzii: Coupling Subtractive Proteomics and Reverse Vaccinology for Vaccine Target Discovery. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011130 | PubMed |
| 40964283 | Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21. | bioRxiv | 2025 | https://conductscience.org/library/papers/40964283 | PubMed |
| 40650846 | Design a multi-epitope vaccine candidate against Acinetobacter baumannii using advanced computational methods. | AMB Express | 2025 | https://conductscience.org/library/papers/40650846 | PubMed |
| 40641804 | Deep learning in next-generation vaccine development for infectious diseases. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40641804 | PubMed |
| 40636082 | Comprehensive immunoinformatics guided design and in silico assessment of a multi-epitope vaccine to elicit immunity against Mayaro virus. | In Silico Pharmacol | 2025 | https://conductscience.org/library/papers/40636082 | PubMed |
| 40583904 | A robust comprehensive immunoinformatics approach for designing a potential multi-epitope based vaccine against a reiterated monkeypox virus. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40583904 | PubMed |
| 40491911 | Studies on nanoprotein vaccine alleviating symptoms of mice allergic to rFel d 1. | Front Immunol | 2025 | https://conductscience.org/library/papers/40491911 | PubMed |
| 40431317 | In Silico Design, Optimization, and Evaluation of a Multi-Epitope Vaccine Targeting the Clostridium perfringens Collagen Adhesin Protein. | Microorganisms | 2025 | https://conductscience.org/library/papers/40431317 | PubMed |
| 40325041 | Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40325041 | PubMed |
| 40297578 | Subtractive proteomics and reverse-vaccinology approaches for novel drug targets and designing a chimeric vaccine against Ruminococcus gnavus strain RJX1120. | Front Immunol | 2025 | https://conductscience.org/library/papers/40297578 | PubMed |
| 40291442 | Targeting immunogenic proteins of Zika virus for the prediction of immunoinformatics-driven circular mRNA vaccine model. | In Silico Pharmacol | 2025 | https://conductscience.org/library/papers/40291442 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9844827
GET https://conductscience.org/api/papers/v1/9844827/references?page=2